Journal of Clinical Endocrinology & Metabolism, Vol 79, 56-61, Copyright © 1994 by Endocrine Society

ARTICLES

Dopamine D2 receptor gene expression and binding sites in adrenal medulla and pheochromocytoma [published erratum appears in J Clin Endocrinol Metab 1994 Oct;79(4):1165]

C Pupilli, R Lanzillotti, G Fiorelli, C Selli, RA Gomez, RM Carey, M Serio and M Mannelli
Department of Clinical Physiopathology, University of Florence, Italy.

To determine whether dopamine D2 receptors are present in normal and neoplastic chromaffin tissues, 10 pheochromocytomas and 5 human adrenal glands were studied. Dopamine D2 receptor messenger ribonucleic acid corresponding to a single band of approximately 2.5 kilobases was detected in both pheochromocytoma and human adrenal gland by Northern blot analysis. D2 receptor messenger ribonucleic acid levels determined by dot blot analysis were 3.1-fold lower in human adrenal medullas than in pheochromocytomas (P < 0.001). Simultaneous Scatchard analysis of [3H]spiperone binding experiments demonstrated the presence of two different binding sites in membrane preparations from bovine adrenal medullas [R1: Kd = 0.14 nmol/L; binding capacity (Bmax) = 6.2 fmol/mg protein: R2: Kd = 16 nmol/L; Bmax = 223 fmol/mg protein]. Similarly, two binding sites were present in membrane preparations from pheochromocytomas (R1: Kd = 0.39 nmol/L; R2: Kd = 61 nmol/L]. Binding capacities were greatly variable among pheochromocytomas (R1: Bmax = 12.0-372.5 fmol/mg protein; R2: Bmax = 1,000-11,586 fmol/mg protein). The relative potencies of different compounds to displace [3H]spiperone were spiperone > domperidone > (+)-butaclamol > quinpirole > SCH 23390 in bovine adrenal medulla, and spiperone >> domperidone > quinpirole > (+)-butaclamol > SCH 23390 in pheochromocytoma. We conclude that dopamine D2 receptors are synthesized in human adrenal medulla and pheochromocytoma tissues.

This article has been cited by other articles:

				R. Pivonello, D. Ferone, G. Lombardi, A. Colao, S. W J Lamberts, and L. J Hofland Novel insights in dopamine receptor physiology Eur. J. Endocrinol., April 1, 2007; 156(suppl_1): S13 - S21. [Abstract] [Full Text] [PDF]

				R. Pivonello, D. Ferone, W. W. de Herder, R. R. de Krijger, M. Waaijers, D. M. Mooij, P. M. van Koetsveld, A. Barreca, M. L. Del Basso De Caro, G. Lombardi, et al. Dopamine Receptor Expression and Function in Human Normal Adrenal Gland and Adrenal Tumors J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4493 - 4502. [Abstract] [Full Text] [PDF]

				E. F. Espejo, M. C. Gonzalez-Albo, J.-P. Moraes, F. El Banoua, J. A. Flores, and I. Caraballo Functional Regeneration in a Rat Parkinson's Model after Intrastriatal Grafts of Glial Cell Line-Derived Neurotrophic Factor and Transforming Growth Factor beta 1-Expressing Extra-Adrenal Chromaffin Cells of the Zuckerkandl's Organ J. Neurosci., December 15, 2001; 21(24): 9888 - 9895. [Abstract] [Full Text] [PDF]

				K.-D. Wu, Y.-M. Chen, T.-S. Chu, S.-C. Chueh, M.-H. Wu, and H. Bor-Shen Expression and Localization of Human Dopamine D2 and D4 Receptor mRNA in the Adrenal Gland, Aldosterone-Producing Adenoma, and Pheochromocytoma J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4460 - 4467. [Abstract] [Full Text] [PDF]

				P. H. Maxwell, C. Buckley, J. M. Gleadle, and P. D. Mason Nasty shock after an anti-emetic Nephrol. Dial. Transplant., May 1, 2001; 16(5): 1069 - 1072. [Full Text] [PDF]

				R. J. Gurrera Sympathoadrenal Hyperactivity and the Etiology of Neuroleptic Malignant Syndrome Am J Psychiatry, February 1, 1999; 156(2): 169 - 180. [Abstract] [Full Text]

				C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON Dopamine Receptors: From Structure to Function Physiol Rev, January 1, 1998; 78(1): 189 - 225. [Abstract] [Full Text] [PDF]

				W. H. Zhu, L. Conforti, and D. E. Millhorn Expression of dopamine D2 receptor in PC-12 cells and regulation of membrane conductances by dopamine Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1143 - C1150. [Abstract] [Full Text] [PDF]

				R. Ozono, D. P. O'Connell, C. Vaughan, S. J. Botkin, S. F. Walk, R. A. Felder, and R. M. Carey Expression of the Subtype 1A Dopamine Receptor in the Rat Heart Hypertension, March 1, 1996; 27(3): 693 - 703. [Abstract] [Full Text]